Propylthiouracil-induced hepatotoxicity and death. Hopefully, never more

Journal of Clinical Endocrinology and Metabolism

Volumn 95, Issue 7, 2010, Pages 3161-3163

  Malozowski, Saul ^a   Chiesa, Ana ^b  

^a NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

^b HOSPITAL DE NIÑOS RICARDO GUTIÉRREZ   (Argentina)

Author keywords

[No Author keywords available]

Indexed keywords

PROPYLTHIOURACIL; THIAMAZOLE; ANTITHYROID AGENT;

DEATH; DRUG FATALITY; DRUG SAFETY; EDITORIAL; FETUS MALFORMATION; HEALTH CARE PERSONNEL; HUMAN; HYPERTHYROIDISM; LIVER TOXICITY; PREGNANCY; PRIORITY JOURNAL; RETROSPECTIVE STUDY; CHILD; NOTE; TOXIC HEPATITIS;

ANTITHYROID AGENTS; CHILD; DRUG-INDUCED LIVER INJURY; HUMANS; METHIMAZOLE; PROPYLTHIOURACIL;

EID: 77954916032     PISSN: 0021972X     EISSN: 0021972X     Source Type: Journal    
DOI: 10.1210/jc.2010-1141     Document Type: Editorial

References (12)

1. Rivkees SA, Szarfman A 2010 Dissimilar hepatotoxicity profiles of propylthiouracil and methimazole in children. J Clin Endocrinol Metab 95:3260-3267
2. Barbero P, Valdez R, Rodriguez H, Tiscornia C, Mansilla E, Allons A, Coll S, Liascovich R 2008 Choanal atresia associated with maternal hyperthyroidism treated with methimazole: a case-control study. Am J Med Genet A 146A:2390-2395
3. Russo MW, Galanko JA, Shrestha R, Fried MW, Watkins P 2004 Liver transplantation for acute liver failure from drug-induced liver injury in the United States. Liver Transpl 10:1018-1023 (Pubitemid 39232756)
4. Emiliano AB, Governale L, Parks M, Cooper DS 2010 Shifts in propylthiouracil and methimazole prescribing practices: antithyroid drug use in the United States from 1991 to 2008. J Clin Endocrinol Metab 95:2227-2233
5. Rivkees SA, Mattison DR 21 April 2009 Propylthiouracil (PTU) hepatoxicity in children and recommendations for discontinuation of use. Int J Pediatr Endocrinol doi: 10.1155/2009/132041
6. Jovanovic BD, Viana MAG, Upper confidence bounds for binomial probability in safety evaluation. Proc of American Statistical Association Biopharmaceutical Section, Alexandria, VA, 1996 (Abstract 140-144)
7. Rogers AS, Israel E, Smith CR, Levine D, McBean AM, Valente C, Faich G 1988 Physician knowledge, attitudes, and behavior related to reporting adverse drug events. Arch Intern Med 148:1596-1600
8. Carleton BC, Smith MA, Gelin MN, Heathcote SC 2007 Paediatric adverse drug reaction reporting: understanding and future directions. Can J Clin Pharmacol 14:e45-e57
9. DuMouchel W, Pregibon D Empirical bayes screening for multi-item associations. Proc of 7th International Conference on Knowledge Discovery and Data Mining, San Francisco, CA, 2001
10. Szarfman A, Machado SG, O'Neill RT 2002 Use of screening algorithms and computer systems to efficiently signal higher-than-expected combinations of drugs and events in the U.S. FDA's spontaneous reports database. Drug Saf 25:381-392
11. Hepatic toxicity following treatment for pediatric Graves' disease. Meeting of Eunice Kennedy Shriver National Institute of Child Health and Human Development, October 28, 2008. http://bpca.nichd.nih.gov/collaborativeefforts/ upload/Hepatic-Toxicity-10- 28-08-final-final-01-09-09.pdf (accessed June 1, 2010)
12. 2009 Information for healthcare professionals - propylthiouracil-induced liver failure. http://www.fda.gov/Drugs/DrugSafety/ PostmarketDrugSafetyInformationforPatientsandProviders/ DrugSafetyInformationforHealthcareProfessionals/ucm162701.htm (accessed May 30, 2010)